Get the Stockscreener App
63.32
4.44%
-2.94
After Hours:
63.25
-0.07
-0.11%
Verona Pharma Plc Adr Stock (VRNA) Forecast
The Verona Pharma Plc Adr (VRNA) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $17.05, representing a -73.07% decrease from the current price of $63.32. The highest analyst price target is $18.34, and the lowest is $15.76.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month VRNA Price Target
Average 22.01
(-65.24% Downside)
Is Verona Pharma Plc Adr (VRNA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 45.42 | Neutral |
| STOCH(9,6) | 51.60 | Neutral |
| STOCHRSI(14) | 4.8746 | Buy |
| MACD(12,26) | 1.9091 | Sell |
| ADX(14) | 22.68 | Neutral |
| William %R | -74.95 | Neutral |
| CCI(14) | -38.76 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
70.01
Sell
|
67.67
Sell
|
| MA20 |
65.35
Sell
|
66.24
Sell
|
| MA50 |
63.89
Sell
|
63.27
Buy
|
| MA100 |
58.73
Buy
|
57.85
Buy
|
| MA200 |
45.05
Buy
|
47.69
Buy
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, VRNA could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 6 signaling Sell signals and 5 Neutral signals. This suggests that investors should exercise caution when entering new positions on VRNA, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 45.42 indicates that VRNA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 51.6 indicates that VRNA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 4.8746 indicates that VRNA is oversold. This suggests that VRNA price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 22.68 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -38.76 indicates that VRNA is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term VRNA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Verona Pharma Plc Adr financial reports and earnings history, Verona Pharma Plc Adr (VRNA) stock could reach $24.94 by 2030, $84.85 by 2040 and $91.30 by 2050. See the projected annual prices until 2050 of the Verona Pharma Plc Adr stock below:
- Verona Pharma Plc Adr (VRNA) is expected to reach an average price of $58.32 in 2035, with a high prediction of $59.94 and a low estimate of $56.78. This indicates an $-7.90% rise from the last recorded price of $63.32.
- Verona Pharma Plc Adr (VRNA) stock is projected to chart a bullish course in 2040, with an average price target of $82.15, representing an $29.74% surge from its current level. The forecast ranges from a conservative $80.46 to a sky-high $84.85.
- Our analysts predict Verona Pharma Plc Adr (VRNA) to jump 34.82% by 2045, soaring from $83.46 to an average price of $85.37, potentially reaching $86.05. While $83.46 is the low estimate, the potential upside is significant.
- Verona Pharma Plc Adr (VRNA) stock is expected to climb by 2050, reaching an average of $91.20, a $44.02% jump from its current level. However, a wide range of estimates exists, with high and low targets of $91.30 and $90.53, respectively, highlighting the market's uncertainty.
Verona Pharma Plc Adr Stock (VRNA) Year by Year Forecast
Verona Pharma Plc Adr Stock (VRNA) Price Forecast for 2025
Verona Pharma Plc Adr Stock (VRNA) is expected to reach an average price of $20.92 in 2025, with a high prediction of $28.25 and a low estimate of $13.59. This indicates an -66.96% fall from the last recorded price of $63.32.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2025 | $16.27 | $15.76 | $18.34 | -74.30% |
| July, 2025 | $17.59 | $16.13 | $18.22 | -72.21% |
| August, 2025 | $17.20 | $16.90 | $18.35 | -72.84% |
| September, 2025 | $20.52 | $16.95 | $28.25 | -67.59% |
| October, 2025 | $19.48 | $18.95 | $21.67 | -69.23% |
| November, 2025 | $19.36 | $19.29 | $20.27 | -69.42% |
| December, 2025 | $19.23 | $18.58 | $19.75 | -69.62% |
Verona Pharma Plc Adr Stock (VRNA) Price Forecast for 2026
The predicted value for Verona Pharma Plc Adr (VRNA) in 2026 is set at an average of $21.46. Estimates vary from a peak of $23.95 to a trough of $18.96, indicating an -66.11% surge from the present price of $63.32.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $20.81 | $18.96 | $21.20 | -67.14% |
| February, 2026 | $21.47 | $20.76 | $21.99 | -66.09% |
| March, 2026 | $21.44 | $20.38 | $21.84 | -66.14% |
| April, 2026 | $23.50 | $21.49 | $23.72 | -62.88% |
| May, 2026 | $22.68 | $22.57 | $23.95 | -64.19% |
| June, 2026 | $23.10 | $21.97 | $23.72 | -63.52% |
| July, 2026 | $20.73 | $20.56 | $23.31 | -67.26% |
| August, 2026 | $22.28 | $20.48 | $22.87 | -64.81% |
| September, 2026 | $20.89 | $20.77 | $22.52 | -67.00% |
| October, 2026 | $21.63 | $20.75 | $21.93 | -65.85% |
| November, 2026 | $21.45 | $20.93 | $22.37 | -66.13% |
| December, 2026 | $21.33 | $20.90 | $22.08 | -66.31% |
Verona Pharma Plc Adr Stock (VRNA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Verona Pharma Plc Adr (VRNA) is $26.59, with a high forecast of $33.07 and a low forecast of $20.11. This indicates an -58.01% decrease from the last price of $63.32.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $21.04 | $20.42 | $21.33 | -66.77% |
| February, 2027 | $21.45 | $21.08 | $21.70 | -66.13% |
| March, 2027 | $21.70 | $20.11 | $22.01 | -65.74% |
| April, 2027 | $23.44 | $21.74 | $23.84 | -62.98% |
| May, 2027 | $22.82 | $22.56 | $23.79 | -63.96% |
| June, 2027 | $22.57 | $22.18 | $23.20 | -64.35% |
| July, 2027 | $22.31 | $21.84 | $22.81 | -64.77% |
| August, 2027 | $21.71 | $21.32 | $22.55 | -65.72% |
| September, 2027 | $22.23 | $21.06 | $22.31 | -64.89% |
| October, 2027 | $22.13 | $22.02 | $23.03 | -65.05% |
| November, 2027 | $22.37 | $21.84 | $22.86 | -64.66% |
| December, 2027 | $31.97 | $22.32 | $33.07 | -49.52% |
Verona Pharma Plc Adr Stock (VRNA) Price Forecast for 2028
In 2028, Verona Pharma Plc Adr (VRNA) is projected to reach an average price of $36.57, with a high projection of $45.97 and a low estimate of $27.17. This indicates an -42.24% fall from the last price of $63.32.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $28.87 | $28.12 | $31.55 | -54.41% |
| February, 2028 | $28.98 | $27.17 | $30.12 | -54.23% |
| March, 2028 | $31.80 | $28.12 | $32.06 | -49.78% |
| April, 2028 | $31.80 | $30.71 | $32.65 | -49.77% |
| May, 2028 | $41.32 | $31.05 | $44.07 | -34.74% |
| June, 2028 | $42.33 | $40.78 | $45.97 | -33.15% |
| July, 2028 | $42.24 | $39.45 | $43.99 | -33.29% |
| August, 2028 | $38.12 | $37.94 | $42.74 | -39.79% |
| September, 2028 | $40.79 | $38.06 | $41.62 | -35.59% |
| October, 2028 | $42.11 | $40.45 | $44.15 | -33.50% |
| November, 2028 | $42.15 | $38.99 | $44.31 | -33.44% |
| December, 2028 | $42.02 | $40.51 | $43.35 | -33.64% |
Verona Pharma Plc Adr Stock (VRNA) Price Forecast for 2029
The 2029 price forecast for Verona Pharma Plc Adr Stock (VRNA) is $34.23 on average, with a high prediction of $44.10 and a low estimate of $24.36. This represents an -45.94% decrease from the previous price of $63.32.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $43.21 | $40.41 | $44.10 | -31.76% |
| February, 2029 | $40.84 | $38.62 | $43.53 | -35.51% |
| March, 2029 | $39.12 | $39.06 | $41.82 | -38.22% |
| April, 2029 | $35.11 | $34.74 | $39.41 | -44.55% |
| May, 2029 | $35.66 | $33.63 | $38.00 | -43.68% |
| June, 2029 | $35.65 | $34.98 | $37.27 | -43.69% |
| July, 2029 | $42.21 | $35.42 | $43.66 | -33.34% |
| August, 2029 | $40.92 | $39.04 | $43.06 | -35.38% |
| September, 2029 | $39.25 | $38.21 | $41.72 | -38.01% |
| October, 2029 | $39.07 | $38.11 | $41.38 | -38.29% |
| November, 2029 | $38.91 | $38.62 | $40.35 | -38.54% |
| December, 2029 | $24.44 | $24.36 | $39.30 | -61.40% |
Verona Pharma Plc Adr Stock (VRNA) Price Forecast for 2030
Verona Pharma Plc Adr Stock (VRNA) is expected to reach an average price of $28.93 in 2030, with a high forecast of $34.80 and a low forecast of $23.05. This signifies an -54.32% decrease from the last price of $63.32.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $24.57 | $24.39 | $24.94 | -61.19% |
| February, 2030 | $24.24 | $24.13 | $24.97 | -61.72% |
| March, 2030 | $24.17 | $23.05 | $24.36 | -61.82% |
| April, 2030 | $24.22 | $23.75 | $25.08 | -61.75% |
| May, 2030 | $25.13 | $24.23 | $25.31 | -60.31% |
| June, 2030 | $25.35 | $24.49 | $25.70 | -59.97% |
| July, 2030 | $25.23 | $25.08 | $26.31 | -60.16% |
| August, 2030 | $26.26 | $25.30 | $26.75 | -58.52% |
| September, 2030 | $28.09 | $26.21 | $34.80 | -55.64% |
| October, 2030 | $29.89 | $27.54 | $30.68 | -52.80% |
| November, 2030 | $26.82 | $26.60 | $30.36 | -57.65% |
| December, 2030 | $27.05 | $25.17 | $28.36 | -57.29% |
0.84%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):